UAE Approves Use of Pfizer-BioNTech Vaccine For 12-15 Age Group
- Publish date: Sunday، 05 December 2021
- Related articles
- Bahrain Approves Use of Oral COVID-19 Antiviral, Paxlovid
- Sheikh Khalid Al Khalifa Honors Bahraini Maryam Jamal with Gold Medal
- Bahrain Tops Global COVID-19 Recovery Index
UAE's Ministry of Health and Prevention (MoHAP) approved the emergency use of the Pfizer- BioNTech vaccine for the 12 to 15 age group, under the outcomes of clinical trials and a strict assessment conducted to approve the emergency local use of the vaccine.
فيديو ذات صلة
This browser does not support the video element.
The approval supports the national efforts to address the coronavirus (COVID-19) pandemic and protect this age group, highlighting the UAE’s proactive approach to ensuring the community’s health and safety.
Read More: UAE Government Employees To Return To Work
The MoHAP, the Department of Health-Abu Dhabi (DoH), the Abu Dhabi Public Health Centre (ADPHC) and the Dubai Health Authority (DHA) launched a free national vaccination campaign for all citizens and residents to curb the spread of COVID-19.
The UAE has provided over 11 million vaccine doses to citizens and residents around the country, which contributed to delivering the declared target of vaccinating half of the eligible population by the end of March 2021.
Image Source: WAM
This article was previously published on UAE Moments.To see the original article, click here